117 related articles for article (PubMed ID: 34284476)
1. False-Positive 123I-Uptake Mimics Metastatic Lung Disease in a Patient With Interstitial Lung Disease Secondary to Scleroderma.
Posocco D; Kamat B; Dadparvar S
Clin Nucl Med; 2022 Jan; 47(1):79-80. PubMed ID: 34284476
[TBL] [Abstract][Full Text] [Related]
2. False-positive 131I whole-body scan in well-differentiated thyroid cancer patient with respiratory bronchiolitis.
Thientunyakit T
Clin Nucl Med; 2013 Sep; 38(9):730-4. PubMed ID: 23510883
[TBL] [Abstract][Full Text] [Related]
3. The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning.
Siddiqi A; Foley RR; Britton KE; Sibtain A; Plowman PN; Grossman AB; Monson JP; Besser GM
Clin Endocrinol (Oxf); 2001 Oct; 55(4):515-21. PubMed ID: 11678835
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory diseases of the lung causing false-positive 131iodine whole body scans in the evaluation of papillary thyroid carcinoma. Two case reports.
Pina JS; Meyer CA; Billingsley JL; Matlock JP; Horan MP; Knodel DH
Chest; 1996 Aug; 110(2):565-7. PubMed ID: 8697869
[TBL] [Abstract][Full Text] [Related]
5. False-Positive Radioactive Iodine Uptake Caused by Cervical Myofascitis in a Patient With Differentiated Thyroid Carcinoma.
Tan X; Wang H; Deng Y; He L; Zhang W
Clin Nucl Med; 2023 Jun; 48(6):512-514. PubMed ID: 37133510
[TBL] [Abstract][Full Text] [Related]
6. Neck and whole-body scanning with 5-mCi dose of (123)I as diagnostic tracer in patients with well-differentiated thyroid cancer.
Gulzar Z; Jana S; Young I; Bukberg P; Yen V; Naddaf S; Abdel-Dayem HM
Endocr Pract; 2001; 7(4):244-9. PubMed ID: 11497474
[TBL] [Abstract][Full Text] [Related]
7. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
[TBL] [Abstract][Full Text] [Related]
8. False-Positive Uptake of Radioiodine in Renal Hamartoma in a Patient With Differentiated Thyroid Cancer.
Shen G; Qi Z; Huang R; Liu B; Kuang A
Clin Nucl Med; 2017 Sep; 42(9):709-710. PubMed ID: 28650888
[TBL] [Abstract][Full Text] [Related]
9. Association between residual thyroid carcinoma and diffuse hepatic uptake of 131I following radioiodine ablation in postoperative total thyroidectomy patients.
Tatar FA; Morita E; Ituarte PH; Cavalieri RR; Duh QY; Price DC; Siperstein AE; Clark OH
World J Surg; 2001 Jun; 25(6):718-22. PubMed ID: 11376405
[TBL] [Abstract][Full Text] [Related]
10. An unusual initial manifestation of metastatic papillary thyroid carcinoma: radioiodine uptake in lymph node metastatic lesions in a patient with Graves' disease.
Newman SL; Griffith AY; Herbst AB; Yeh IT; Kukora JS
Endocr Pract; 2002; 8(4):304-6. PubMed ID: 12173918
[TBL] [Abstract][Full Text] [Related]
11. 123I accumulation in thoracic neoesophagus masking residual papillary thyroid cancer.
Jackson T; Sabbah N; Iagaru A
Clin Nucl Med; 2015 Feb; 40(2):e150-1. PubMed ID: 24999691
[TBL] [Abstract][Full Text] [Related]
12. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.
Grewal RK; Tuttle RM; Fox J; Borkar S; Chou JF; Gonen M; Strauss HW; Larson SM; Schöder H
J Nucl Med; 2010 Sep; 51(9):1361-7. PubMed ID: 20720058
[TBL] [Abstract][Full Text] [Related]
13. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
15. Incidental finding of a dermoid cyst in a whole-body iodine scan: importance of using [131I]SPECT/CT in the differentiated thyroid carcinoma.
Mohammadzadeh Kosari H; Zakavi SR; Barashki S; Roustaei Firouzabad H; Ataei Nakhaei S; Aryana K
Nucl Med Rev Cent East Eur; 2021; 24(2):106-107. PubMed ID: 34382676
[TBL] [Abstract][Full Text] [Related]
16. Iodine-123 uptake in vertebral haemangiomas in a patient with papillary thyroid carcinoma.
Khan S; Dunn J; Strickland N; Al-Nahhas A
Nucl Med Rev Cent East Eur; 2008; 11(1):30-3. PubMed ID: 19173186
[TBL] [Abstract][Full Text] [Related]
17. Diffuse 131I lung uptake in bronchiectasis: a potential pitfall in the follow-up of differentiated thyroid carcinoma.
Triggiani V; Moschetta M; Giagulli VA; Licchelli B; Guastamacchia E
Thyroid; 2012 Dec; 22(12):1287-90. PubMed ID: 23067330
[TBL] [Abstract][Full Text] [Related]
18. 123I isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer: comparison with post 131I therapy whole body scanning.
Alzahrani AS; Bakheet S; Al Mandil M; Al-Hajjaj A; Almahfouz A; Al Haj A
J Clin Endocrinol Metab; 2001 Nov; 86(11):5294-300. PubMed ID: 11701695
[TBL] [Abstract][Full Text] [Related]
19. Comparison of post-therapeutic sequential 131I whole-body scans in the detection of metastatic thyroid cancer.
Qiu L; Tan H; Yin H; Zhou J; Cheng D; Shi H
Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):313-320. PubMed ID: 30221907
[TBL] [Abstract][Full Text] [Related]
20. The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.
Ali N; Sebastian C; Foley RR; Murray I; Canizales AL; Jenkins PJ; Drake WM; Plowman PN; Besser GM; Chew SL; Grossman AB; Monson JP; Britton KE
Nucl Med Commun; 2006 Feb; 27(2):165-9. PubMed ID: 16404230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
